• 2-Thio-dCTP: A Causal Assay Design Guide

  2026-08-27

  Explore how 2-Thio-dCTP and 2-Thio-2'-deoxycytidine-5'-Triphosphate support mechanistic DNA experiments while remaining distinct from histone-phosphorylation biology. This guide connects nucleotide chemistry with SCP4–H3T3 research to improve assay interpretation and experimental controls.

• BENPs Enhance FLASH-RT Radioimmunotherapy

  2026-08-26

  The reference study reports that functionalized, self-assembled epigallocatechin gallate nanoparticles, termed BENPs, can sensitize 4T1 tumors to FLASH radiotherapy while promoting antitumor immune responses. Its integrated analysis of oxidative stress, DNA damage, tumor control, safety, and immune remodeling provides a useful framework for evaluating radiosensitizers beyond direct cytotoxicity alone.

• Reactive Oxygen Species Assay Kit: DHE Workflow

  2026-08-26

  Turn live-cell superoxide detection into a practical readout for mitochondrial quality control, pulmonary fibrosis models, and apoptosis research. This workflow explains how to use DHE signal alongside PINK1–Parkin and fibrosis endpoints without mistaking superoxide-responsive fluorescence for total ROS.

• Erastin Workflows for Ferroptosis Research

  2026-08-25

  Use Erastin as a controlled ferroptosis inducer to connect cystine depletion, glutathione loss, ROS accumulation, and tumor-cell vulnerability. This practical workflow translates recent GPR68 and radiation findings into assay designs for RAS/BRAF models, A549 or Panc02 cells, 2D cultures, and 3D colony systems.

• Making RNAi Visible: From Mechanism to Spatial Proof

  2026-08-25

  A translational framework for using Cy3-labeled RNA probes to connect RNAi mechanism, spatial evidence, and assay strategy, with practical guidance on selecting and optimizing the HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit.

• Bestatin as a Chemical Genetics Tool for Jasmonate Signaling

  2026-08-24

  The reference study established bestatin as a chemical probe for activating and dissecting jasmonate signaling in Arabidopsis. By combining gene-expression analysis, pathway-dependency tests, developmental phenotyping, and screening for bestatin-resistant mutants, the authors identified genetic entry points into jasmonate-regulated defense and growth responses.

• Carfilzomib (PR-171): From Proteostasis to Cell Death

  2026-08-23

  Carfilzomib (PR-171) links irreversible proteasome blockade to ER stress and multi-modal tumor-cell death. This article presents an assay-centered framework for studying proteasome inhibition, radiation sensitization, and mechanistic readout selection in cancer research.

• Urolithin A: Reliable Cell Assay Workflows

  2026-08-22

  Learn how Urolithin A (SKU B7945) can be integrated into reproducible viability, proliferation, and mitochondrial assays. This scenario-driven guide covers assay interpretation, compound handling, cross-study comparison, and practical product-selection criteria.

• ATRX Loss Sensitizes Glioma Cells to RTK Inhibitors

  2026-08-21

  The reference study used an FDA-approved drug screen to identify a selective vulnerability of ATRX-deficient high-grade glioma cells to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its combination data further suggest that ATRX status may help interpret RTK inhibitor trials and guide temozolomide-based treatment research.

• Sunitinib: Multi-Targeted RTK Inhibitor Guide

  2026-08-20

  Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor that blocks VEGFR, PDGFR, KIT, and RET signaling in cancer research models. Its strongest research applications include tumor angiogenesis, apoptosis, cell-cycle analysis, and renal cell carcinoma resistance studies, with product-specific handling requirements for DMSO stocks and low-temperature storage.

• GDC-0994: A Mechanistic ERK1/2 Research Guide

  2026-08-20

  Explore how GDC-0994 functions as a selective ERK1/2 inhibitor and how its use can connect oncology signaling assays with mechanistic cholestasis research. This guide emphasizes causal experimental design, pathway readouts, and interpretation limits.

• Doxycycline Hyclate in MMP Assay Design

  2026-08-19

  Doxycycline hyclate is a matrix metalloproteinases inhibitor that can reveal how MMP-linked barrier injury contributes to neurovascular dysfunction. This article translates a mouse arsenic-neurotoxicity study into a rigorous framework for endpoint selection, formulation control, and cross-domain interpretation.

• Canagliflozin (hemihydrate): Assay Guide

  2026-08-19

  This scenario-based guide explains how Canagliflozin (hemihydrate), SKU C6434, can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing SGLT2 biology with nonspecific assay effects. It covers solvent preparation, controls, interpretation of mTOR-related findings, and practical criteria for selecting a reliable research-grade material.

• Esflurbiprofen and Fast-Onset Antidepressant Action

  2026-08-18

  The reference study identifies disruption of the SERT–nNOS complex in the dorsal raphe nucleus as a strategy for accelerating antidepressant responses. Using mBRET-based screening, stress-induced mouse models, molecular assays, and resting-state fMRI, the authors connect PDZ-domain targeting with altered serotonergic feedback and improved depressive-like behaviors.

• EZ Cap™ Cas9 mRNA (5-moUTP) for Viability Assays

  2026-08-18

  This scenario-driven guide explains how Cas9 mRNA quality, delivery conditions, and assay controls affect viability, proliferation, and cytotoxicity experiments. It positions EZ Cap™ Cas9 mRNA (5-moUTP), SKU R1015, within practical CRISPR-Cas9 genome editing workflows while separating product specifications from evidence generated in disease-model studies.

441 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page